1. Home
  2. BYSI

BYSI

BeyondSpring Inc.

Logo BeyondSpring Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform. It has a scalable business model integrating clinical resources in the United States and China.

Founded: 2010 Country:
United States
United States
Employees: N/A City: N/A
Market Cap: 68.7M IPO Year: 2017
Target Price: $1.25 AVG Volume (30 days): 226.2K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.71 EPS Growth: N/A
52 Week Low/High: $0.65 - $4.00 Next Earning Date: 04-14-2022
Revenue: $1,550,000 Revenue Growth: 29.92%
Revenue Growth (this year): 5.7% Revenue Growth (next year): N/A

Share on Social Networks: